Open Access

ARTICLE

Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway

TIANYING CAI^1,2, JUNJIE BAI¹, PENG TAN³, ZHIWEI HUANG¹, CHEN LIU¹, ZIMING WU¹, YONGLANG CHENG¹, TONGXI LI¹, YIFAN CHEN¹, JIAN RUAN⁴, LIN GAO⁵, YICHAO DU^3,*, WENGUANG FU^1,3,*

1 Department of Hepatobiliary Surgery, Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China
2 Biobank, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China
3 Academician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China
4 Department of Medical Oncology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China
5 Department of Health Management, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China

* Corresponding Authors: YICHAO DU. Email: ; WENGUANG FU. Email: